198 records, the earliest from 11 Nov 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
198 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Category | Subject |
|---|---|---|
| 16 Oct 2024 13:22 | Delisting | Members of the Exchange are hereby informed about the delisting of equity shares of Celestial Biolabs Limited w.e.f. October 17, 2024 in terms of Rule 21(2) (b) of the Securities Contracts (Regulations) Rules 1957. |
| 23 Jul 2024 06:41 | Appointment | Celestial Biolabs Limited has informed the Exchange regarding Appointment of Mr Dattatreya Rao as Executive Director of the company w.e.f. April 22, 2024. |
| 30 May 2024 12:09 | Board meeting Cancelled | This is to inform you that the Board Meeting of the company which was scheduled on 30.05.2024 stand cancelled due to non-finalization of accounts |
| 23 May 2024 12:26 | Shareholders meeting | Celestial Biolabs Limited has informed the Exchange regarding voting results of Annual General Meeting held on May 23, 2024 |
| 23 May 2024 12:24 | Shareholders meeting | Celestial Biolabs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on May 23, 2024 |
| 23 May 2024 12:21 | Shareholders meeting | Celestial Biolabs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on May 23, 2024 |
| 16 May 2024 13:40 | Disclosure under SEBI Takeover Regulations | Celestial Biolabs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| 14 May 2024 10:34 | Clarification - Financial Results | The Exchange has sought clarification from Celestial Biolabs Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted -2. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited. |
| 10 May 2024 13:45 | Clarification - Financial Results | The Exchange has sought clarification from Celestial Biolabs Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited. |
| 10 May 2024 13:45 | Clarification - Financial Results | The Exchange has sought clarification from Celestial Biolabs Limited for the quarter ended 30-Sep-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited. |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
